Zeasorb

Manufacturer
Stiefel Laboratories Inc
Effective date
2018-11-16
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
legacy-cache
Hydrated at
2026-08-02 00:47:03

Label at a glance#

ProductZeasorb
Active ingredientMICONAZOLE NITRATE
Label structure12 sections

Dosage and administration

• clean the affected area and dry thoroughly • apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor • supervise children in the use of this product • pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily • use daily for 4 weeks • if condition persists longer, consult a doctor •...

Storage and handling

Store below 25°C (77°F). Product settles during shipment. Package contains full net weight.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Miconazole nitrate 2%

Purpose

OTC - PURPOSE SECTION

Antifungal

Use (Athlete's Foot)

INDICATIONS & USAGE SECTION

for the cure of most athlete's foot

Use (Jock Itch)

INDICATIONS & USAGE SECTION

for the cure of most jock itch

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • on children under 2 years of age unless directed by a doctor.

Avoid contact with the eyes.

Stop use and ask a doctor if (Athlete's Foot)

OTC - STOP USE SECTION

  • irritation occurs or there is no improvement within 4 weeks.

Stop use and ask a doctor if (Jock Itch)

OTC - STOP USE SECTION

  • irritation occurs or there is no improvement within 2 weeks.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions (Athlete's Foot)

DOSAGE & ADMINISTRATION SECTION

  • clean the affected area and dry thoroughly
  • apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product
  • pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily
  • use daily for 4 weeks
  • if condition persists longer, consult a doctor
  • this product is not effective on the scalp or nails

Directions (Jock Itch)

DOSAGE & ADMINISTRATION SECTION

  • clean the affected area and dry thoroughly.
  • apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Avoid open wounds.
  • supervise children in the use of this product.
  • use daily for 2 weeks.
  • if condition persists longer, consult a doctor.
  • this product is not effective on the scalp or nails.

Other information

STORAGE AND HANDLING SECTION

Store below 25°C (77°F). Product settles during shipment. Package contains full net weight.

Inactive ingredients

INACTIVE INGREDIENT SECTION

aldioxa, chloroxylenol, fragrance, imidurea, powdered cellulose, sodium polyacrylate, talc

Questions?

OTC - QUESTIONS SECTION

call 1-888-438-7426

Distributed by: Stiefel Laboratories, Inc., Research Triangle Park, NC 27709

Made in India

Trademarks are owned by or licensed to the GSK group of companies.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0145-1506-05

Super Absorbent Powder

Zeasorb® AF

ANTIFUNGAL TREATMENT

Miconazole Nitrate 2%

Super Absorbent Powder

cures most athlete's foot

Relieves:

  • Itching
  • Burning
  • Scaling

#1 Dermatologist Recommended

Stiefel

Net wt. 2.5 OZ (71 g)

©2015 GSK or its licensor. All rights reserved.

Front Label: 103580XC

103580XC_Zeasorb Athlete's Foot_2.5 oz.jpg
103580XC_Zeasorb Athlete's Foot_2.5 oz.jpg

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0145-1501-03

Super Absorbent Powder

Zeasorb® AF

ANTIFUNGAL TREATMENT

Miconazole Nitrate 2%

cures most jock itch

Relieves:

  • Itching
  • Burning
  • Scaling

#1 Dermatologist Recommended

Stiefel

Net wt. 2.5 OZ (71 g)

©2015 GSK or its licensor. All rights reserved

Front Label: 103658XB

103658XB_Zeasorb Jock Itch_2.5 oz.jpg
103658XB_Zeasorb Jock Itch_2.5 oz.jpg

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0145-1506-05GM - Gram0145-15061e1923de-6ede-4349-bb9c-a7e5d5a40ad712012-07-24
0145-1501-03GM - Gram0145-15018db7623b-3232-4642-b6db-5ccdb5b53ace12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
MICONAZOLE NITRATEACTIVE INGREDIENTVW4H1CYW1K6
MICONAZOLEACTIVE MOIETY7NNO0D7S5M6
ACRYLAMIDEINACTIVE INGREDIENT20R035KLCI6
ALDIOXAINACTIVE INGREDIENT8T66I31YNK6
CHLOROXYLENOLINACTIVE INGREDIENT0F32U78V2Q6
IMIDUREAINACTIVE INGREDIENTM629807ATL6
POWDERED CELLULOSEINACTIVE INGREDIENTSMD1X3XO9M6
TALCINACTIVE INGREDIENT7SEV7J4R1U6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0145-15060145-1506-05, 0145-1506-61, 0145-1506-01
0145-15010145-1501-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 56 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
TALCTALC7SEV7J4R1UCAPSULE, COATED, EXTENDED RELEASE / ORAL20 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UGUM, CHEWING / BUCCALNAExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1USUSPENSION, EXTENDED RELEASE / ORAL46 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1ULOZENGE / ORAL50 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, DELAYED RELEASE / ORAL420 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, COATED / ORAL320.75 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE, EXTENDED RELEASE / ORAL18 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / ORAL1000 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, FOR SUSPENSION / ORAL24 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, EXTENDED RELEASE / ORAL5119 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UELIXIR / ORAL4.5 mg/5mlExact identifier — unii candidate
35 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLSHAMPOO / TOPICAL60 mgExact identifier — unii candidate
3 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MPOWDER, FOR SUSPENSION / ORAL1600 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MDROPS / ORALNAExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, DELAYED RELEASE / ORAL16 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MPASTE, DENTIFRICE / DENTALNAExact identifier — unii candidate
16 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED PELLETS / ORAL14 mgExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MLIQUID / ORALNAExact identifier — unii candidate
16 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, FILM COATED, EXTENDED RELEASE / ORAL60 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE PARTICLES / ORAL56 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, ORALLY DISINTEGRATING / ORAL80 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE / ORAL729 mgExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, FILM COATED / ORAL392 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET / ORAL1582 mgExact identifier — unii candidate
16 equally ranked IID candidates
CHLOROXYLENOLCHLOROXYLENOL0F32U78V2QCREAM / TOPICAL0.15 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
TALCTALC7SEV7J4R1UPELLET / ORAL69 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, EXTENDED RELEASE / ORAL300 mgExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MSUSPENSION / ORAL1600 mgExact identifier — unii candidate
16 equally ranked IID candidates
TALCTALC7SEV7J4R1UPOWDER / TOPICAL9235 mgExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, COATED / ORAL40.2 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET / SUBLINGUAL4.5 mgExact identifier — unii candidate
16 equally ranked IID candidates
TALCTALC7SEV7J4R1UPOWDER, FOR SUSPENSION / ORAL735 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE, FOR SUSPENSION / ORAL296 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MDISC / TOPICALNAExact identifier — unii candidate
16 equally ranked IID candidates
TALCTALC7SEV7J4R1UOINTMENT / TOPICAL74.6 %w/wExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED / ORAL87 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1USUSPENSION / ORAL234 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE / ORAL349 mgExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, CHEWABLE / ORALNAExact identifier — unii candidate
16 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLLOTION / TOPICAL228 mgExact identifier — unii candidate
3 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE, DELAYED RELEASE / ORAL525 mgExact identifier — unii candidate
35 equally ranked IID candidates
CHLOROXYLENOLCHLOROXYLENOL0F32U78V2QSOLUTION / AURICULAR (OTIC)0.1 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / RECTAL32.4 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / SUBLINGUAL32.4 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL357 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE / ORAL202 mgExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET, EXTENDED RELEASE / ORAL156 mgExact identifier — unii candidate
16 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MCAPSULE / ORAL2430 mgExact identifier — unii candidate
16 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / BUCCAL15 mgExact identifier — unii candidate
35 equally ranked IID candidates
IMIDUREAIMIDUREAM629807ATLCREAM / TOPICAL0.4 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE / ORAL322 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UDROPS / ORALNAExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MTABLET / BUCCAL4.5 mgExact identifier — unii candidate
16 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, FILM COATED / ORAL91 mgExact identifier — unii candidate
35 equally ranked IID candidates
POWDERED CELLULOSEPOWDERED CELLULOSESMD1X3XO9MDISC / EXTRACORPOREALNAExact identifier — unii candidate
16 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8ea2db47-91b8-47e7-947c-6be4ff9d4185c8260a34-ea4d-46d9-b9de-0cdd689be5c92018-11-16WarningsExact identifier
spl id: 8ea2db47-91b8-47e7-947c-6be4ff9d4185
spl set id: c8260a34-ea4d-46d9-b9de-0cdd689be5c9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.